3 Ways to Double Your $10K TFSA in 2020 (Without Being Dumb)

Tired of declines? This trio of momentum stocks, including National Bank of Canada (TSX:NA), might have the rocket fuel you need.

edit Close-up Of A Piggybank With Eyeglasses And Calculator On Desk

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Hi there, Fools. I’m back to quickly highlight three stocks trading at new 52-week highs. Why? Because after a given stock rallies over a short period of time, one of two things usually happens:

While momentum stocks are on the fickle side, they can often rally higher (and for longer) than you might expect. So, if you’re looking to double your TFSA in 2020, this list might be a good place to begin.

Let’s get to it.

Bankable bet

Leading off our list is financial services company National Bank of Canada, whose shares are up 17% over the past year and are trading near 52-week highs of about $71 per share.

National Bank’s outperformance continues to be fueled by its leadership position in Quebec, impressive scale (total assets of $276 billion), and highly stable cash flows.

In the most recent quarter, income increased 7% as revenue improved 5% to $891 million. More importantly, the company’s capital and leverage ratios remained healthy.

“Each business segment contributed to earnings growth, helping the Bank to post solid performance in the third quarter of fiscal 2019,” said CEO Louis Vachon.

National Bank shares offer a solid dividend yield of 3.8%.

Feeling healthy

Next up, we have pharmaceutical company Bausch Health Companies, which is up about 30% over the past year and currently trades near 52-week highs of $44.50 per share.

Bausch’s market-leading product portfolio, diversified revenue stream (pharmaceuticals, medical devices, OTC products), and potent pipeline should continue to drive solid gains in 2020. In the most recent quarter, EPS of $1.19 topped expectations by $0.10 as revenue improved 3% to $2.2 billion.

“In the third quarter, Bausch Health delivered another strong quarter with both reported and organic revenue growth, demonstrating that our efforts to grow our core businesses are continuing to gain traction,” said Chairman and CEO Joseph Papa.

Bausch Health shares currently trade at a forward P/E of 6.3.

Silver surfer

Rounding out our list is silver miner Silvercorp Metals, whose shares are up a massive 160% over the past year and trade near 52-week highs of $6.80 per share.

Silvercorp’s massive gains continue to be supported by strong metals prices, extremely low production costs, and a rock-solid balance sheet. In the most recent quarter, EPS of $0.07 topped estimates by $0.03 on revenue improvement of 4%. Silvercorp also generated operating cash flow of $26 million, up 24% from the year-ago period.

More importantly, management only expects things to get better.

“The company expects its consolidated production in fiscal 2020 will exceed its annual guidance and that production costs will be within the budget,” wrote the company.

Silvercorp currently trades at a forward P/E of 29.

The bottom line

There you have it, Fools: three red-hot momentum stocks worth checking out.

As always, they aren’t formal recommendations. Instead, look at them as a starting point for further research. Momentum stocks are especially fickle, so plenty of your own due diligence is required.

Fool on.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. The Motley Fool owns shares of and recommends Bausch Health Companies.

More on Dividend Stocks

growing plant shoots on stacked coins
Dividend Stocks

5 Dividend Stocks to Buy With Yields Upwards of 5%

These five companies all earn tonnes of cash flow, making them some of the best long-term dividend stocks you can…

Read more »

funds, money, nest egg
Dividend Stocks

TFSA Investors: 3 Stocks to Start Building an Influx of Passive Income

A TFSA is the ideal registered account for passive income, as it doesn't weigh down your tax bill, and any…

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Dividend Stocks

3 of the Safest Dividend Stocks in Canada

Royal Bank of Canada stock is one of the safest TSX dividend stocks to buy. So is CT REIT and…

Read more »

Growing plant shoots on coins
Dividend Stocks

1 of the Top Canadian Growth Stocks to Buy in February 2023

Many top Canadian growth stocks represent strong underlying businesses, healthy financials, and organic growth opportunities.

Read more »

stock research, analyze data
Dividend Stocks

Wherever the Market Goes, I’m Buying These 3 TSX Stocks

Here are three TSX stocks that could outperform irrespective of the market direction.

Read more »

woman data analyze
Dividend Stocks

1 Oversold Dividend Stock (Yielding 6.5%) to Buy This Month

Here's why SmartCentres REIT (TSX:SRU.UN) is one top dividend stock that long-term investors should consider in this current market.

Read more »

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Dividend Stocks

Better TFSA Buy: Enbridge Stock or Bank of Nova Scotia

Enbridge and Bank of Nova Scotia offer high yields for TFSA investors seeking passive income. Is one stock now undervalued?

Read more »

Golden crown on a red velvet background
Dividend Stocks

2 Top Stocks Just Became Canadian Dividend Aristocrats

These two top Canadian Dividend Aristocrats stocks are reliable companies with impressive long-term growth potential.

Read more »